Industry Solutions
See how Incredible Health doubled meetings booked with a 3-day go-live. 510(k) clearances, hospital partnerships, GPO contracts, and executive moves — ready in minutes.
Selling medical technology is an exercise in navigating complexity. Hospital procurement committees, group purchasing organizations (GPOs), and value analysis committees create multi-layered buying processes where clinical evidence, cost-effectiveness, and vendor relationships all matter. Sellers need to understand each health system's strategic priorities, technology infrastructure, and clinical workflow challenges before they can earn a seat at the table. Surface-level account research gets filtered out immediately.
The med tech industry is undergoing a wave of transformation. AI-enabled medical devices are proliferating, with FDA AI/ML clearances up 40% year-over-year. Hospital procurement is tightening under value-based care models, demanding stronger ROI justification. Med tech M&A is surging as companies acquire digital health capabilities. And the GLP-1 drug revolution is reshaping demand for bariatric, cardiovascular, and metabolic device markets. Each of these shifts creates selling opportunities for companies that can detect them early.
Med tech sales also requires understanding the clinical-to-commercial pipeline. When Medtronic receives a 510(k) clearance for a new device, competitors need to respond. When Boston Scientific partners with a major hospital system, it reshapes the competitive landscape. Tracking these buying signals across Stryker, Abbott, Becton Dickinson, and dozens of other players requires intelligence that updates in real time.
510(k) Clearances & FDA Decisions
New device clearances, PMA approvals, and De Novo classifications that signal competitive product launches and market entry
Hospital System Partnerships
Strategic partnerships between med tech companies and health systems, including exclusive distribution agreements and clinical collaboration deals
GPO Contract Changes
Group purchasing organization contract awards, renewals, and competitive displacements that reshape vendor access to hospital networks
Executive & Clinical Leadership Moves
CEO transitions, Chief Medical Officer appointments, and VP of Sales hires that indicate strategic direction shifts and new vendor evaluation cycles
M&A and Digital Health Acquisitions
Med tech acquisitions of digital health companies, surgical robotics firms, and AI/analytics startups that reshape product portfolios
Earnings & Revenue Guidance
Quarterly earnings commentary on growth segments, geographic expansion, and product category investments from public med tech companies
Incredible Health's team needed to identify and engage hospital decision-makers at scale. Manual research across health systems was slow, and reps lacked the real-time signals needed to time their outreach to moments of genuine buying intent in the healthcare ecosystem.
Salesmotion enabled Incredible Health to go live in just 3 days and double their meetings booked. The team now accesses real-time intelligence on health system priorities, leadership changes, and expansion signals — engaging decision-makers at the moment opportunities emerge.
“There's been a big focus on hyper personalization and relevance in our outbounding efforts. Salesmotion has been a key partner in hitting our significantly increased meeting targets. What stands out is how simple it is. Reps can log in and get valuable account insights within 30 seconds to a minute.”
Joe DeFrance
VP of Sales, Incredible Health
Incredible Health results
more meetings booked
to go live
more quarterly meetings
Everything your reps need to research accounts, spot buying signals, and craft relevant outreach.
Monitor 510(k) clearances, PMA approvals, and regulatory decisions across the med tech landscape. Know when competitors receive device clearances, when new product categories emerge, and when regulatory changes create market shifts.
Track hospital system partnerships, capital expenditure announcements, and technology adoption decisions. Identify which health systems are investing in new device categories and when procurement cycles open.
Monitor group purchasing organization contract awards, competitive displacements, and supply chain consolidation. Know when GPO contracts are shifting and which vendors are gaining or losing access to hospital networks.
Extract executive commentary on growth segments, product launches, and market strategy from quarterly earnings calls. Understand what Medtronic, Stryker, and Abbott leadership is telling investors about their priorities. See our guide to analyzing earnings calls.
Generate messaging that references specific device launches, clinical evidence, and health system priorities at each target account. Demonstrate the clinical and commercial fluency that med tech buyers demand.
Understand how target med tech companies position themselves by device category, clinical specialty, and geographic market. Track competitive product launches, M&A activity, and market share shifts in real time.
See how Salesmotion stacks up against manual research and generic CRM data for your industry.
| Feature | Manual Research | Generic CRM Data | Salesmotion |
|---|---|---|---|
| Med tech-specific intelligence | Tracking FDA databases, hospital announcements, and GPO contracts manually | Basic company data with no medical device or healthcare context | Deep med tech profiles including device portfolio, regulatory status, hospital partnerships, and competitive positioning |
| Device clearance tracking | Monitoring FDA.gov 510(k) database and press releases individually | No coverage of medical device regulatory events | Automated alerts for 510(k) clearances, PMA approvals, and regulatory decisions |
| Account research time | 3-4 hours per med tech account across clinical and regulatory sources | Surface-level data that lacks healthcare industry depth | Complete med tech account intelligence in minutes with AI-generated talking points |
| Hospital partnership visibility | Manually checking press releases and hospital system websites | No visibility into health system partnerships and procurement | Automated monitoring of hospital partnerships, GPO contracts, and procurement decisions |
| Competitive intelligence | Ad-hoc tracking of competitor product launches and regulatory filings | Generic competitive data with no device category context | Real-time monitoring of competitive device launches, M&A activity, and market positioning shifts |
Common questions about Salesmotion for Med Tech
Med tech buyers operate in a highly regulated, evidence-driven environment. Salesmotion provides comprehensive account intelligence including device portfolios, regulatory milestones, hospital partnerships, and competitive positioning — enabling reps to engage decision-makers with genuine clinical and commercial understanding.
Yes. Salesmotion monitors FDA regulatory decisions including 510(k) clearances, PMA approvals, and De Novo classifications across the med tech landscape. When competitors receive device clearances or new product categories emerge, your team is alerted with contextual talking points.
Salesmotion tracks GPO contract awards, hospital system partnerships, and procurement decisions. Understanding when contracts are shifting, which health systems are investing in new device categories, and when procurement cycles open helps sellers time their outreach for maximum impact.
Incredible Health, a healthcare technology company selling to hospital systems, doubled meetings booked and went live in just 3 days with Salesmotion. Their team now engages health system decision-makers with real-time intelligence on priorities, leadership changes, and expansion signals.
Med tech sales involves device-specific regulatory pathways (510(k) vs NDA), hospital procurement committees, and GPO contracts — different from pharma's drug pipeline and clinical trial dynamics. Salesmotion covers both — see our pharma and life sciences pages for pharmaceutical-specific intelligence.
GLP-1 drugs are reshaping demand for bariatric surgery devices, cardiovascular devices, and metabolic monitoring equipment. Salesmotion tracks these market dynamics through earnings call analysis, helping med tech sellers understand which product categories are growing or contracting due to GLP-1 adoption.
Have a question we didn't cover? Talk to our team
Book a personalized demo and see how real-time signals and AI research help med tech teams close more deals.
Join the top-performing sales teams using Salesmotion to build more pipeline and close more deals.
Book a demo
